This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Redhill Biopharma Ltd (RDHL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012
Cash and Equivalents 5.89M 11.87M 17.30M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 17.05M 427.00K 1.06M
Total Current Assets 26.02M 12.60M 18.56M
Property, Plant & Equipment, Gross 236.00K 166.00K 113.00K
Accumulated Depreciation & Depletion 90.00K 63.00K 0.00
Property, Plant & Equipment, Net 146.00K 103.00K 113.00K
Intangibles 2.62M 1.55M 1.34M
Other Non-Current Assets 76.00K 81.00K 75.00K
Total Non-Current Assets 2.84M 1.74M 1.53M
Liabilities & Shareholder Equity
Total Assets 28.86M 14.34M 20.10M
Accounts Payable 1.72M 1.15M 507.00K
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00
Total Current Liabilities 1.72M 2.42M 1.08M
Long Term Debt 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 2.12M 0.00 0.00
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 2.12M 0.00 0.00
Total Liabilities 3.85M 2.42M 1.08M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 25.01M 11.93M 19.02M
Common Par 240.00K 174.00K 143.00K
Additional Paid In Capital 65.46M 43.14M 31.47M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -42.22M -33.26M -23.89M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 1.53M 1.87M 11.29M
Total Capitalization 25.01M 11.93M 19.02M
Total Equity 25.01M 11.93M 19.02M
Total Liabilities & Stock Equity 28.86M 14.34M 20.10M
Total Common Shares Outstanding 12.70M 6.44M 5.30M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 8.66M 6.24M 5.26M
Diluted Weighted Shares Outstanding 8.66M 6.24M 5.26M
Number of Employees 10 8 7
Number of Part-Time Employees 0 2 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RDHL Redhill Biopharma Ltd

Chart of RDHL

Analysts Ratings for RDHL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 2 3 3
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

RDHL Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs